Literature DB >> 12947546

[Effects of the novel gene, LAPTM4B, highly expression in hepatocellular carcinoma on cell proliferation and tumorigenesis of NIH3T3 cells].

Jing He1, Genze Shao, Rouli Zhou.   

Abstract

OBJECTIVE: To study the biological effects of the novel gene LAPTM4B high expressed in hepatocellular carcinoma on cell proliferation and tumorigenesis of NIH3T3 cells.
METHODS: Eukaryotic expression plasmid pcDNA3-TM4B was constructed and transfected into mouse NIH3T3 cell line using Lipofectamin-2000 mediating gene transfer technique. Monoclonal transfected cells with high expression of LAPTM4B gene were identified and selected by RT-PCR, Northern blot and Western blot method. Cell surface morphology was detected by scanning electronic microscopy (SEM). The cell attachment/spreading on various matrices was examined. The cell growth curves were measured by acid phosphatase method. Cell cycle was detected by flow cytometry (FCM). The expression level of Cyclin E protein was examined using Western blot.
RESULTS: The cell surface of the LAPTM4B transfected cells showed abundant tube/finger-like microvilli, which were distinguished significantly from the MOCK cells. The cell attachment/spreading of transfected cells increased on fibronectin, matrigel and laminin. The growth rate of transfected cells was faster than that of the MOCK cells. FCM analysis indicated that the amount of the transfected cells in S phase was increased significantly. Cyclin E protein expression of transfected cells was much higher than that of the MOCK cell. The serum-dependence of transfected cells was decreased. The fibrosarcoma was formed at a tumorigenic rate of 50% in NIH mice inoculated with LAPTM4B transfected cells.
CONCLUSION: LAPTM4B gene promotes the cell proliferation by involving in the regulation of cell cycle control and causes tumorigenesis of NIH3T3 cells, indicating that it plays important roles in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12947546

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  14 in total

1.  Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.

Authors:  Xin-Rong Liu; Rou-Li Zhou; Qing-Yun Zhang; Ye Zhang; Yue-Ying Jin; Ming Lin; Jing-An Rui; Da-Xiong Ye
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

2.  Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma.

Authors:  Cong Peng; Rou-Li Zhou; Gen-Ze Shao; Jing-An Rui; Shao-Bin Wang; Ming Lin; Sha Zhang; Zi-Feng Gao
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

3.  [Serum LAPTM4B-35 protein as a novel diagnostic marker for hepatocellular carcinoma].

Authors:  Y Pang; S Zhang; H Yang; R L Zhou
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-18

4.  LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.

Authors:  Hua Yang; Fu Xia Xiong; Ming Lin; Yu Yang; Xiu Nie; Rou Li Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-19       Impact factor: 4.553

5.  Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population.

Authors:  Bing Wang; Jianjun Xu; Rouli Zhou; Qingyun Zhang
Journal:  Med Oncol       Date:  2013-01-24       Impact factor: 3.064

6.  Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis.

Authors:  Maojin Li; Rouli Zhou; Yi Shan; Li Li; Lin Wang; Gang Liu
Journal:  Oncotarget       Date:  2016-09-06

7.  A role for the ubiquitin ligase Nedd4 in membrane sorting of LAPTM4 proteins.

Authors:  Ruth Milkereit; Daniela Rotin
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

8.  LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.

Authors:  Xiaojing Cheng; Zhixue Zheng; Zhaode Bu; Xiaojiang Wu; Lianhai Zhang; Xiaofang Xing; Xiaohong Wang; Ying Hu; Hong Du; Lin Li; Shen Li; Rouli Zhou; Xian-Zi Wen; Jia-Fu Ji
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

9.  The relationship between LAPTM4B polymorphisms and cancer risk in Chinese Han population: a meta-analysis.

Authors:  Ling-Zi Xia; Zhi-Hua Yin; Yang-Wu Ren; Li Shen; Wei Wu; Xue-Lian Li; Peng Guan; Bao-Sen Zhou
Journal:  Springerplus       Date:  2015-04-15

10.  LAPTM4B polymorphism increases susceptibility to multiple cancers in Chinese populations: a meta-analysis.

Authors:  Cuiju Mo; Yu Lu; Yan Deng; Jian Wang; Li Xie; Taijie Li; Yu He; Qiliu Peng; Xue Qin; Shan Li
Journal:  BMC Genet       Date:  2014-04-18       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.